---
figid: PMC4982433__12957_2016_969_Fig3_HTML
figlink: /pmc/articles/PMC4982433/figure/Fig3/
number: F3
caption: 'Signalling pathway and targeted therapy in gastric cancer. Percentages signify
  the overall molecular characteristics in the disease: FGFR2 amplification (9 %),
  VEGF/VEGFR overexpression (36–40 %), EGFR amplification and overexpression (27–44 %),
  HER2 amplification and overexpression (7–34 %), c-MET amplification (10–15 %), kRAS
  mutation (2–20 %), Raf mutation (0–3 %), PI3K mutation (4–36 %), phospho-Akt expression
  (29–86 %), phospho-mTOR expression (60–88 %), PTCH1 overexpression (16%), SMO overexpression
  (12%), and HER3 mutations (10%, not shown). *No clinical trials of these agents
  have yet been reported in gastric cancer. ‡No known numbers or percentages for these
  genes and pathways. Abbreviations: EGFR epidermal growth factor receptor, FGFR fibroblast
  growth factor receptor, GLI glioma-associated oncogene family zinc finger 1, HDAC
  histone deacetylase, HER human epidermal growth factor receptor, HGF hepatocyte
  growth factor, Hh Hedgehog, IGFR insulin-like growth factor receptor, MMP matrix
  metalloproteinase, mTOR mammalian target of rapamycin, PDGFR platelet-derived growth
  factor receptor, Ptch-1 protein patched homolog 1, Smo smoothened, VEGF vascular
  endothelial growth factor, VEGFR vascular endothelial growth factor receptor (reproduced
  with permission from Wadhwa, R. et al. Nat. Rev. Clin. Oncol. 10, 643–655 (2013)
  [])'
pmcid: PMC4982433
papertitle: 'Gastric biomarkers: a global review.'
reftext: Nick Baniak, et al. World J Surg Oncol. 2016;14:212.
pmc_ranked_result_index: '45279'
pathway_score: 0.9712005
filename: 12957_2016_969_Fig3_HTML.jpg
figtitle: Signalling pathway and targeted therapy in gastric cancer
year: '2016'
organisms:
- Homo sapiens
ndex: 47d040ec-dec7-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC4982433__12957_2016_969_Fig3_HTML.html
  '@type': Dataset
  description: 'Signalling pathway and targeted therapy in gastric cancer. Percentages
    signify the overall molecular characteristics in the disease: FGFR2 amplification
    (9 %), VEGF/VEGFR overexpression (36–40 %), EGFR amplification and overexpression
    (27–44 %), HER2 amplification and overexpression (7–34 %), c-MET amplification
    (10–15 %), kRAS mutation (2–20 %), Raf mutation (0–3 %), PI3K mutation (4–36 %),
    phospho-Akt expression (29–86 %), phospho-mTOR expression (60–88 %), PTCH1 overexpression
    (16%), SMO overexpression (12%), and HER3 mutations (10%, not shown). *No clinical
    trials of these agents have yet been reported in gastric cancer. ‡No known numbers
    or percentages for these genes and pathways. Abbreviations: EGFR epidermal growth
    factor receptor, FGFR fibroblast growth factor receptor, GLI glioma-associated
    oncogene family zinc finger 1, HDAC histone deacetylase, HER human epidermal growth
    factor receptor, HGF hepatocyte growth factor, Hh Hedgehog, IGFR insulin-like
    growth factor receptor, MMP matrix metalloproteinase, mTOR mammalian target of
    rapamycin, PDGFR platelet-derived growth factor receptor, Ptch-1 protein patched
    homolog 1, Smo smoothened, VEGF vascular endothelial growth factor, VEGFR vascular
    endothelial growth factor receptor (reproduced with permission from Wadhwa, R.
    et al. Nat. Rev. Clin. Oncol. 10, 643–655 (2013) [])'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - HDAC3
  - PDGFRB
  - HDAC11
  - KDR
  - HDAC2
  - HDAC8
  - HDAC10
  - HDAC1
  - PDGFRA
  - HDAC7
  - FLT4
  - MTOR
  - HDAC4
  - RAF1
  - SIRT6
  - HDAC9
  - PIK3CD
  - PIK3CG
  - HRAS
  - SIRT1
  - PIK3R3
  - PTCH1
  - SIRT7
  - AKT3
  - KRAS
  - SIRT5
  - AKT2
  - MET
  - PIK3CB
  - PGF
  - VEGFA
  - VEGFB
  - VEGFC
  - FLT1
  - AKT1
  - PIK3R5
  - HDAC5
  - PDK1
  - PIK3R6
  - HGF
  - IGF1R
  - HDAC6
  - ERBB2
  - EZH2
  - KMT2C
  - KMT2A
  - EPM2A
  - SIRT3
  - VEGFD
  - PIK3R4
  - EGFR
  - SIRT2
  - GLI1
  - SMO
  - PIK3CA
  - FGFR2
  - NRAS
  - SIRT4
  - Perifosine
  - Dovitinib
  - Regorafenib
  - BMS833923
  - Cancer
  - Lung cancer
genes:
- word: HDAC
  symbol: HDAC
  source: bioentities_symbol
  hgnc_symbol: HDAC3
  entrez: '8841'
- word: PDGFR*
  symbol: PDGFR
  source: bioentities_symbol
  hgnc_symbol: PDGFRB
  entrez: '5159'
- word: HDAC
  symbol: HDAC
  source: bioentities_symbol
  hgnc_symbol: HDAC11
  entrez: '79885'
- word: VEGFR
  symbol: VEGFR
  source: bioentities_symbol
  hgnc_symbol: KDR
  entrez: '3791'
- word: HDAC
  symbol: HDAC
  source: bioentities_symbol
  hgnc_symbol: HDAC2
  entrez: '3066'
- word: HDAC
  symbol: HDAC
  source: bioentities_symbol
  hgnc_symbol: HDAC8
  entrez: '55869'
- word: HDAC
  symbol: HDAC
  source: bioentities_symbol
  hgnc_symbol: HDAC10
  entrez: '83933'
- word: HDAC
  symbol: HDAC
  source: bioentities_symbol
  hgnc_symbol: HDAC1
  entrez: '3065'
- word: PDGFR*
  symbol: PDGFR
  source: bioentities_symbol
  hgnc_symbol: PDGFRA
  entrez: '5156'
- word: HDAC
  symbol: HDAC
  source: bioentities_symbol
  hgnc_symbol: HDAC7
  entrez: '51564'
- word: VEGFR
  symbol: VEGFR
  source: bioentities_symbol
  hgnc_symbol: FLT4
  entrez: '2324'
- word: MTOR
  symbol: MTOR
  source: hgnc_symbol
  hgnc_symbol: MTOR
  entrez: '2475'
- word: HDAC
  symbol: HDAC
  source: bioentities_symbol
  hgnc_symbol: HDAC4
  entrez: '9759'
- word: Raf1
  symbol: RAF1
  source: hgnc_symbol
  hgnc_symbol: RAF1
  entrez: '5894'
- word: HDAC
  symbol: HDAC
  source: bioentities_symbol
  hgnc_symbol: SIRT6
  entrez: '51548'
- word: HDAC
  symbol: HDAC
  source: bioentities_symbol
  hgnc_symbol: HDAC9
  entrez: '9734'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: HRAS
  entrez: '3265'
- word: HDAC
  symbol: HDAC
  source: bioentities_symbol
  hgnc_symbol: SIRT1
  entrez: '23411'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: Ptch-1
  symbol: PTCH1
  source: hgnc_symbol
  hgnc_symbol: PTCH1
  entrez: '5727'
- word: HDAC
  symbol: HDAC
  source: bioentities_symbol
  hgnc_symbol: SIRT7
  entrez: '51547'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: KRAS
  entrez: '3845'
- word: HDAC
  symbol: HDAC
  source: bioentities_symbol
  hgnc_symbol: SIRT5
  entrez: '23408'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: c-MET
  symbol: MET
  source: hgnc_symbol
  hgnc_symbol: MET
  entrez: '4233'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: PGF
  entrez: '5228'
- word: VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFA
  entrez: '7422'
- word: VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFB
  entrez: '7423'
- word: VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFC
  entrez: '7424'
- word: VEGFR
  symbol: VEGFR
  source: bioentities_symbol
  hgnc_symbol: FLT1
  entrez: '2321'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: HDAC
  symbol: HDAC
  source: bioentities_symbol
  hgnc_symbol: HDAC5
  entrez: '10014'
- word: PDK-1
  symbol: PDK1
  source: hgnc_symbol
  hgnc_symbol: PDK1
  entrez: '5163'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: HGF
  symbol: HGF
  source: hgnc_symbol
  hgnc_symbol: HGF
  entrez: '3082'
- word: IGFR
  symbol: IGFR
  source: hgnc_alias_symbol
  hgnc_symbol: IGF1R
  entrez: '3480'
- word: HDAC
  symbol: HDAC
  source: bioentities_symbol
  hgnc_symbol: HDAC6
  entrez: '10013'
- word: HER2
  symbol: HER-2
  source: hgnc_alias_symbol
  hgnc_symbol: ERBB2
  entrez: '2064'
- word: (EZH2,
  symbol: EZH2
  source: hgnc_symbol
  hgnc_symbol: EZH2
  entrez: '2146'
- word: (EZH2,ARID,KMT2C,KMT2A)
  symbol: KMT2C
  source: hgnc_symbol
  hgnc_symbol: KMT2C
  entrez: '58508'
- word: KMT2A)
  symbol: KMT2A
  source: hgnc_symbol
  hgnc_symbol: KMT2A
  entrez: '4297'
- word: LDE
  symbol: LDE
  source: hgnc_alias_symbol
  hgnc_symbol: EPM2A
  entrez: '7957'
- word: HDAC
  symbol: HDAC
  source: bioentities_symbol
  hgnc_symbol: SIRT3
  entrez: '23410'
- word: VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFD
  entrez: '2277'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: EGFR/HER1
  symbol: EGFR
  source: hgnc_symbol
  hgnc_symbol: EGFR
  entrez: '1956'
- word: HDAC
  symbol: HDAC
  source: bioentities_symbol
  hgnc_symbol: SIRT2
  entrez: '22933'
- word: GLI
  symbol: GLI
  source: hgnc_prev_symbol
  hgnc_symbol: GLI1
  entrez: '2735'
- word: SMO
  symbol: SMO
  source: hgnc_symbol
  hgnc_symbol: SMO
  entrez: '6608'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: FGFR2
  symbol: FGFR2
  source: hgnc_symbol
  hgnc_symbol: FGFR2
  entrez: '2263'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: NRAS
  entrez: '4893'
- word: HDAC
  symbol: HDAC
  source: bioentities_symbol
  hgnc_symbol: SIRT4
  entrez: '23409'
chemicals:
- word: Perifosine
  source: MESH
  identifier: C105905
- word: Dovitinib
  source: MESH
  identifier: C500007
- word: Regorafenib
  source: MESH
  identifier: C559147
- word: BMS833923
  source: MESH
  identifier: C583051
diseases:
- word: Cancer
  source: ''
  identifier: ''
- word: Lung cancer
  source: ''
  identifier: ''
figid_alias: PMC4982433__F3
redirect_from: /figures/PMC4982433__F3
figtype: Figure
---
